Immunovirotherapy for the treatment of glioblastoma
Citation
Cheema, Tooba A, Peter E Fecci, Jianfang Ning, and Samuel D Rabkin. 2014. “Immunovirotherapy for the treatment of glioblastoma.” Oncoimmunology 3 (1): e27218. doi:10.4161/onci.27218. http://dx.doi.org/10.4161/onci.27218.Abstract
We have recently described a new murine model of glioblastoma, generated by the implantation of syngeneic glioblastoma stem cells into immunocompetent mice, that recapitulates the salient histopathological and immunological features of the human disease. We employed this model to demonstrate the multifaceted activity of an oncolytic herpes simplex virus genetically modified to express interleukin-12, G47∆-IL12.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929360/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879877
Collections
- HMS Scholarly Articles [17875]
Contact administrator regarding this item (to report mistakes or request changes)